BNT162b2 Variant-Adapted Vaccine in Healthy Adults
Clinical Trial Grant
Awarded By
Pfizer, Inc.
Start Date
May 5, 2026
End Date
November 6, 2027
Awarded By
Pfizer, Inc.
Start Date
May 5, 2026
End Date
November 6, 2027